Matches in SemOpenAlex for { <https://semopenalex.org/work/W1981055539> ?p ?o ?g. }
- W1981055539 endingPage "2518" @default.
- W1981055539 startingPage "2518" @default.
- W1981055539 abstract "<h3>Importance</h3> The established chronic kidney disease (CKD) progression end point of end-stage renal disease (ESRD) or a doubling of serum creatinine concentration (corresponding to a change in estimated glomerular filtration rate [GFR] of −57% or greater) is a late event. <h3>Objective</h3> To characterize the association of decline in estimated GFR with subsequent progression to ESRD with implications for using lesser declines in estimated GFR as potential alternative end points for CKD progression. Because most people with CKD die before reaching ESRD, mortality risk also was investigated. <h3>Data Sources and Study Selection</h3> Individual meta-analysis of 1.7 million participants with 12 344 ESRD events and 223 944 deaths from 35 cohorts in the CKD Prognosis Consortium with a repeated measure of serum creatinine concentration over 1 to 3 years and outcome data. <h3>Data Extraction and Synthesis</h3> Transfer of individual participant data or standardized analysis of outputs for random-effects meta-analysis conducted between July 2012 and September 2013, with baseline estimated GFR values collected from 1975 through 2012. <h3>Main Outcomes and Measures</h3> End-stage renal disease (initiation of dialysis or transplantation) or all-cause mortality risk related to percentage change in estimated GFR over 2 years, adjusted for potential confounders and first estimated GFR. <h3>Results</h3> The adjusted hazard ratios (HRs) of ESRD and mortality were higher with larger estimated GFR decline. Among participants with baseline estimated GFR of less than 60 mL/min/1.73 m<sup>2</sup>, the adjusted HRs for ESRD were 32.1 (95% CI, 22.3-46.3) for changes of −57% in estimated GFR and 5.4 (95% CI, 4.5-6.4) for changes of −30%. However, changes of −30% or greater (6.9% [95% CI, 6.4%-7.4%] of the entire consortium) were more common than changes of −57% (0.79% [95% CI, 0.52%-1.06%]). This association was strong and consistent across the length of the baseline period (1 to 3 years), baseline estimated GFR, age, diabetes status, or albuminuria. Average adjusted 10-year risk of ESRD (in patients with a baseline estimated GFR of 35 mL/min/1.73 m<sup>2</sup>) was 99% (95% CI, 95%-100%) for estimated GFR change of −57%, was 83% (95% CI, 71%-93%) for estimated GFR change of −40%, and was 64% (95% CI, 52%-77%) for estimated GFR change of −30% vs 18% (95% CI, 15%-22%) for estimated GFR change of 0%. Corresponding mortality risks were 77% (95% CI, 71%-82%), 60% (95% CI, 56%-63%), and 50% (95% CI, 47%-52%) vs 32% (95% CI, 31%-33%), showing a similar but weaker pattern. <h3>Conclusions and Relevance</h3> Declines in estimated GFR smaller than a doubling of serum creatinine concentration occurred more commonly and were strongly and consistently associated with the risk of ESRD and mortality, supporting consideration of lesser declines in estimated GFR (such as a 30% reduction over 2 years) as an alternative end point for CKD progression." @default.
- W1981055539 created "2016-06-24" @default.
- W1981055539 creator A5005549802 @default.
- W1981055539 creator A5006359202 @default.
- W1981055539 creator A5011285126 @default.
- W1981055539 creator A5013622079 @default.
- W1981055539 creator A5020840981 @default.
- W1981055539 creator A5024425228 @default.
- W1981055539 creator A5029705769 @default.
- W1981055539 creator A5032482746 @default.
- W1981055539 creator A5032690087 @default.
- W1981055539 creator A5045539647 @default.
- W1981055539 creator A5047227825 @default.
- W1981055539 creator A5047992802 @default.
- W1981055539 creator A5048680434 @default.
- W1981055539 creator A5054296834 @default.
- W1981055539 creator A5063861062 @default.
- W1981055539 creator A5064422444 @default.
- W1981055539 creator A5068244845 @default.
- W1981055539 creator A5071859593 @default.
- W1981055539 creator A5073636956 @default.
- W1981055539 creator A5073772726 @default.
- W1981055539 creator A5074587712 @default.
- W1981055539 creator A5074978138 @default.
- W1981055539 creator A5077012508 @default.
- W1981055539 creator A5078723203 @default.
- W1981055539 creator A5083633514 @default.
- W1981055539 creator A5086558284 @default.
- W1981055539 creator A5086855818 @default.
- W1981055539 date "2014-06-25" @default.
- W1981055539 modified "2023-10-17" @default.
- W1981055539 title "Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality" @default.
- W1981055539 cites W1570583414 @default.
- W1981055539 cites W1968675464 @default.
- W1981055539 cites W1973002697 @default.
- W1981055539 cites W1983970448 @default.
- W1981055539 cites W1985406570 @default.
- W1981055539 cites W1993611425 @default.
- W1981055539 cites W2044434363 @default.
- W1981055539 cites W2048196288 @default.
- W1981055539 cites W2052396810 @default.
- W1981055539 cites W2053091007 @default.
- W1981055539 cites W2064576408 @default.
- W1981055539 cites W2081231656 @default.
- W1981055539 cites W2096923533 @default.
- W1981055539 cites W2104443849 @default.
- W1981055539 cites W2114956091 @default.
- W1981055539 cites W2118112768 @default.
- W1981055539 cites W2121473391 @default.
- W1981055539 cites W2121637153 @default.
- W1981055539 cites W2126662750 @default.
- W1981055539 cites W2128783545 @default.
- W1981055539 cites W2131525218 @default.
- W1981055539 cites W2137004892 @default.
- W1981055539 cites W2140155018 @default.
- W1981055539 cites W2142172228 @default.
- W1981055539 cites W2146105386 @default.
- W1981055539 cites W2155965977 @default.
- W1981055539 cites W2159132936 @default.
- W1981055539 cites W2467227824 @default.
- W1981055539 cites W2615684303 @default.
- W1981055539 cites W2319268509 @default.
- W1981055539 doi "https://doi.org/10.1001/jama.2014.6634" @default.
- W1981055539 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4172342" @default.
- W1981055539 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24892770" @default.
- W1981055539 hasPublicationYear "2014" @default.
- W1981055539 type Work @default.
- W1981055539 sameAs 1981055539 @default.
- W1981055539 citedByCount "724" @default.
- W1981055539 countsByYear W19810555392014 @default.
- W1981055539 countsByYear W19810555392015 @default.
- W1981055539 countsByYear W19810555392016 @default.
- W1981055539 countsByYear W19810555392017 @default.
- W1981055539 countsByYear W19810555392018 @default.
- W1981055539 countsByYear W19810555392019 @default.
- W1981055539 countsByYear W19810555392020 @default.
- W1981055539 countsByYear W19810555392021 @default.
- W1981055539 countsByYear W19810555392022 @default.
- W1981055539 countsByYear W19810555392023 @default.
- W1981055539 crossrefType "journal-article" @default.
- W1981055539 hasAuthorship W1981055539A5005549802 @default.
- W1981055539 hasAuthorship W1981055539A5006359202 @default.
- W1981055539 hasAuthorship W1981055539A5011285126 @default.
- W1981055539 hasAuthorship W1981055539A5013622079 @default.
- W1981055539 hasAuthorship W1981055539A5020840981 @default.
- W1981055539 hasAuthorship W1981055539A5024425228 @default.
- W1981055539 hasAuthorship W1981055539A5029705769 @default.
- W1981055539 hasAuthorship W1981055539A5032482746 @default.
- W1981055539 hasAuthorship W1981055539A5032690087 @default.
- W1981055539 hasAuthorship W1981055539A5045539647 @default.
- W1981055539 hasAuthorship W1981055539A5047227825 @default.
- W1981055539 hasAuthorship W1981055539A5047992802 @default.
- W1981055539 hasAuthorship W1981055539A5048680434 @default.
- W1981055539 hasAuthorship W1981055539A5054296834 @default.
- W1981055539 hasAuthorship W1981055539A5063861062 @default.
- W1981055539 hasAuthorship W1981055539A5064422444 @default.
- W1981055539 hasAuthorship W1981055539A5068244845 @default.
- W1981055539 hasAuthorship W1981055539A5071859593 @default.